HOME >> BIOLOGY >> NEWS
Robust time estimation reconciles views of the antiquity of placental mammals

Despite great progress over the past decade, the evolutionary history of placental mammals remains controversial. While a consensus is emerging on the topology of the evolutionary tree, although with occasional disagreement, divergence times remain uncertain. The age of earlier nodes and in particular the root, remain especially uncertain in the absence of definitive placental fossils deeper into the Cretaceous. Both paleontological and morphological studies suggest that the radiation of placental orders and super orders occurred close to the CretaceousTertiary (KT) boundary about 65 million years ago (mya). In contrast, molecular studies have suggested markedly older origins for many superordinal groups and that some extant orders diversified before the KT boundary.

However, this discrepancy may not be real, but rather appear because of the violation of implicit assumptions in the estimation procedures, such as abrupt acceleration of evolutionary rate entangled with gradual variation and large-scale convergent evolution in molecular level. By their new robust procedure, Dr. Kitazoe and his collaborators identified a strong and short-term acceleration of mitochondrial genome along the lineage leading to Laurasiatheria. The revised time at the root of placental mammals was much younger than the preceding reports, 84 million years ago instead of around 122 million years ago. As a result, the estimated distribution of molecular divergence times is broadly consistent with quantitative analysis of the North American fossil record and traditional morphological views. They emphasize the necessity to scrutinize the implicit assumptions adopted by the models of molecular evolution and to develop procedures which rely little on those assumptions.


'"/>

Contact: Yasuhiro Kitazoe
kitazoey@kochi-u.ac.jp
Public Library of Science
17-Apr-2007


Page: 1

Related biology news :

1. Local range estimation in wild animals
2. Neuroblastoma expert reviews progress and challenges in fighting difficult pediatric cancer
3. New findings challenge established views on human genome
4. New findings challenge established views about human genome
5. Public shares views on environmental, health and safety research needs for nanoscale materials
6. Handling HPV vaccines and screening: The views of 100 authors
7. Through a satellite darkly: Night views of European seas improve ESA ocean heat map
8. Avian flu in perspective: New England Journal article reviews spectacular findings
9. New study into public views on diet and health research published
10. Technological revolutions in sensors, robotics, and telecommunications allow new views of ocean
11. New study highlights universality of public views toward science and technology

Post Your Comments:
(Date:5/24/2013)... disease, scientists have focused among other factors on ... it is the accumulation of A-beta that causes the known ... the formation of A-beta is APP. Alessia Soldano and Bassem ... of APPL the fruit-fly version of APP in ... (VIB/KU Leuven): "We have discovered that APPL ensures that brain ...
(Date:5/23/2013)... Automated conserved noncoding sequence (CNS) discovery reveals differences ... , Within the genome of each species, there are ... in position and sequence over millions of years, but ... evolutionarily stable sequences, so-called conserved noncoding sequences (CNSs), are ... the condensation of chromosomes, but the function of many ...
(Date:5/23/2013)... honored more than 165 staff for their creation, ... annual Intellectual Property Commercialization Recognition & Rewards Program ... laboratory named materials scientist Jun Liu Inventor of ... that can store large amounts of energy, ease ... time it takes to charge cell phones, electric ...
Breaking Biology News(10 mins):A new strategy required in the search for Alzheimer's drugs? 2Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3PNNL staff recognized for scientific accomplishments, moving technologies into the marketplace 2
(Date:5/24/2013)... May 24, 2013 Vestiage, Inc. ... company focused on science-based research and development, sales ... cosmeceuticals and nutraceuticals, announced today that it is ... for the sale of Reluma Skin Illuminating Facial ... and application by sending an email to info(at)vestiageinc(dot)com ...
(Date:5/23/2013)... Every day, their baby stopped breathing, his collapsed bronchus ... April and Bryan Gionfriddo watched helplessly, just praying that ... few doctors said he had a good chance of ... her now 20-month-old son, Kaiba. "At that point, we ... it and run with it." , They found hope ...
(Date:5/23/2013)... 23, 2013 Can economic incentives such ... motivate members of the public to increase their donations ... Johns Hopkins Carey Business School Assistant Professor Mario ... to a large body of recent research that supports ... 24, 2013, issue of Science that the World Health ...
(Date:5/23/2013)... May 23, 2013 PuraMed BioScience ® ... marketer of over-the-counter (OTC) medicinal and healthcare products, ... on the company based on low market capitalization ... Non-Prescription, All Natural Product to Treat Migraine Headaches ... #1 Prescription Competitor , Currently Available Nationwide ...
Breaking Biology Technology:Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5Baby's life saved with groundbreaking 3-D printed device that restored his breathing 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 3Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 2PuraMed BioScience (PMBS) Issued Alert Based on Market Cap of $721,756 3
Cached News: